Genesis Therapeutics
AI-Powered Drug Discovery
Description:
Genesis Therapeutics is a biotechnology company that uses artificial intelligence (AI) to discover and develop new drugs. The company's platform combines 3D spatial graph modeling and cutting-edge molecular simulation to generate novel drug candidates. Genesis Therapeutics is working to develop new therapies for patients suffering from severe disorders, such as cancer and neurodegenerative diseases.
The company was founded in 2016 by a team of proven drug hunters, deep learning researchers, and software engineers. Genesis Therapeutics has raised over $200 million in funding from investors such as Andreessen Horowitz, Lilly Asia Ventures, and Roche Venture Fund.
For Tasks:
For Jobs:
Features
- 3D spatial graph modeling
- Cutting-edge molecular simulation
- AI-driven drug discovery
- Novel drug candidate generation
- Accelerated drug development
Advantages
- Unveils novel protein targets
- Explores untapped chemical space
- Accelerates the development of critical new medicines
- Utilizes the industry's most advanced molecular AI platform
- Drives AI in biochemistry
Disadvantages
- Limited to drug discovery and development
- Requires extensive data and computational resources
- May not be suitable for all types of drug discovery projects
Frequently Asked Questions
-
Q:What is Genesis Therapeutics?
A:Genesis Therapeutics is a biotechnology company that uses AI to discover and develop new drugs. -
Q:What is the company's platform?
A:The company's platform combines 3D spatial graph modeling and cutting-edge molecular simulation to generate novel drug candidates. -
Q:What diseases is Genesis Therapeutics focused on?
A:The company is focused on developing new therapies for patients suffering from severe disorders, such as cancer and neurodegenerative diseases. -
Q:Who founded Genesis Therapeutics?
A:The company was founded in 2016 by a team of proven drug hunters, deep learning researchers, and software engineers. -
Q:How much funding has Genesis Therapeutics raised?
A:The company has raised over $200 million in funding from investors such as Andreessen Horowitz, Lilly Asia Ventures, and Roche Venture Fund.
Alternative AI tools for Genesis Therapeutics
Similar sites
Lavo Life Sciences
Accelerate Drug Development with Accurate Crystal Structure Prediction
Institute for Protein Design
We create new proteins that solve modern challenges in medicine, technology, and sustainability.
Stanford Artificial Intelligence Laboratory
Stanford Artificial Intelligence Laboratory: Where AI comes to life
For similar tasks
Lavo Life Sciences
Accelerate Drug Development with Accurate Crystal Structure Prediction
For similar jobs
Lavo Life Sciences
Accelerate Drug Development with Accurate Crystal Structure Prediction
